Evidence map›Paper›PMID 39618569›Full record

ArticleCureus2024

Epidemiology and Treatment Outcomes of Renal Cell Carcinoma in Qassim Region, Saudi Arabia: A Retrospective Study.

Badr Alharbi, Hatim S Alnosayan, Faisal Awadh Al-Harbi, Alwleed M Alaidah, Albaraa Nasser Almoshiqeh, Abdullah Mulfi Alharbi, Emad Alwashmi, Adil Khalaf Altwairgi

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Badr AlharbiSurgery, College of Medicine, Qassim University, Buraydah, SAU.
Hatim S AlnosayanUrology, Medical City, Qassim University, Buraydah, SAU.
Faisal Awadh Al-HarbiSurgery, College of Medicine, Qassim University, Buraydah, SAU.
Alwleed M AlaidahMedicine, Qassim University, Buraydah, SAU.
Albaraa Nasser AlmoshiqehSurgery, College of Medicine, Qassim University, Buraydah, SAU.
Abdullah Mulfi AlharbiSurgery, College of Medicine, Qassim University, Buraydah, SAU.
Emad AlwashmiSurgery, College of Medicine, Qassim University, Buraydah, SAU.
Adil Khalaf AltwairgiSurgery, Unaizah Medical College, Qassim University, Buraydah, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

INTRODUCTION AND

aimRenal cell carcinoma (RCC) is an aggressive malignant neoplasm that accounts for 90% of renal cancers with rising incidence worldwide. This study aimed to analyze the demographics and clinical profiles, histopathological presentations, and treatment outcomes of 73 RCC patients at a hospital in Qassim region, Saudi Arabia. METHODOLOGY: This retrospective observational study was conducted at King Fahad Specialist Hospital, Buraidah, from October 2017 to July 2024. Census sampling included all patients diagnosed with RCC. Data on demographics, clinical, and histopathological characteristics were analyzed using SPSS version 26 (Armonk, NY: IBM Corp.).

resultsRCC was found to be more prevalent in males and older patients with common comorbidities such as diabetes and hypertension. Among the histopathological types of RCC, clear cell RCC (ccRCC) is most frequently reported in 60.3% of patients, followed by chromophobe RCC (chRCC) and papillary RCC (pRCC), in 16.4% and 11% of patients, respectively. Fuhrman grade 2 stage was seen in 65.8% of the tumors, indicating its moderately aggressive form. Incidental diagnoses accounted for 45.2% of patients, with 93.2% demonstrating no evidence of metastasis at diagnosis. The primary mode of treatment of RCC was the surgical procedure with laparoscopy, which was undergone in 52.1% of cases.

conclusionccRCC exhibits the highest prevalence among the various forms of renal cancer, with the majority of cases being diagnosed incidentally. Despite the rising incidence, early diagnosis and improved screening strategies are yet to be elucidated to address the growing burden of RCC and its incidental finding rate in the Qassim region.

Indexed as

ccrcccomorbiditykidney tumorrenal cell carcinomasaudi arabia

Identifiers

PMID39618569
PMCPMC11607626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.